584 related articles for article (PubMed ID: 20220840)
1. Targeting early infection to prevent HIV-1 mucosal transmission.
Haase AT
Nature; 2010 Mar; 464(7286):217-23. PubMed ID: 20220840
[TBL] [Abstract][Full Text] [Related]
2. Overview of the landscape of HIV prevention.
Haase AT
Am J Reprod Immunol; 2014 Jun; 71(6):490-4. PubMed ID: 24702688
[TBL] [Abstract][Full Text] [Related]
3. Mucosal immune dysfunction in AIDS pathogenesis.
Paiardini M; Frank I; Pandrea I; Apetrei C; Silvestri G
AIDS Rev; 2008; 10(1):36-46. PubMed ID: 18385779
[TBL] [Abstract][Full Text] [Related]
4. Mucosal immunity, HIV transmission, and AIDS.
Miller CJ; McGhee JR; Gardner MB
Lab Invest; 1993 Feb; 68(2):129-45. PubMed ID: 8441249
[No Abstract] [Full Text] [Related]
5. Mucosal Vaccination for Prevention of HIV Infection and AIDS.
Aldovini A
Curr HIV Res; 2016; 14(3):247-59. PubMed ID: 26957199
[TBL] [Abstract][Full Text] [Related]
6. Nonhuman primate models for cell-associated simian immunodeficiency virus transmission: the need to better understand the complexity of HIV mucosal transmission.
Bernard-Stoecklin S; Gommet C; Cavarelli M; Le Grand R
J Infect Dis; 2014 Dec; 210 Suppl 3():S660-6. PubMed ID: 25414421
[TBL] [Abstract][Full Text] [Related]
7. Cytotoxic T lymphocytes in AIDS pathogenesis: lessons to be learned from the macaque model of simian immunodeficiency virus infection.
Geretti AM; Hulskotte E; Osterhaus AD
J Gen Virol; 1998 Mar; 79 ( Pt 3)():415-21. PubMed ID: 9519818
[No Abstract] [Full Text] [Related]
8. Mucosal immunology of HIV infection.
Xu H; Wang X; Veazey RS
Immunol Rev; 2013 Jul; 254(1):10-33. PubMed ID: 23772612
[TBL] [Abstract][Full Text] [Related]
9. Early events in sexual transmission of HIV and SIV and opportunities for interventions.
Haase AT
Annu Rev Med; 2011; 62():127-39. PubMed ID: 21054171
[TBL] [Abstract][Full Text] [Related]
10. AIDS and mucosal immunity: usefulness of the SIV macaque model of genital mucosal transmission.
Miller C; Gardner MB
J Acquir Immune Defic Syndr (1988); 1991; 4(12):1169-72. PubMed ID: 1941523
[No Abstract] [Full Text] [Related]
11. Perils at mucosal front lines for HIV and SIV and their hosts.
Haase AT
Nat Rev Immunol; 2005 Oct; 5(10):783-92. PubMed ID: 16200081
[TBL] [Abstract][Full Text] [Related]
12. Transmission, acute HIV-1 infection and the quest for strategies to prevent infection.
Pope M; Haase AT
Nat Med; 2003 Jul; 9(7):847-52. PubMed ID: 12835704
[TBL] [Abstract][Full Text] [Related]
13. Introduction: Back to basics: mucosal immunity and novel HIV vaccine concepts.
Broliden K; Haase AT; Ahuja SK; Shearer GM; Andersson J
J Intern Med; 2009 Jan; 265(1):5-17. PubMed ID: 19093956
[No Abstract] [Full Text] [Related]
14. Mucosal transmission of virulent and avirulent lentiviruses in macaques.
Pauza CD; Horejsh D; Wallace M
AIDS Res Hum Retroviruses; 1998 Apr; 14 Suppl 1():S83-7. PubMed ID: 9581890
[TBL] [Abstract][Full Text] [Related]
15. Changing paradigms for an HIV vaccine.
Schultz AM
Adv Exp Med Biol; 1996; 397():79-90. PubMed ID: 8718586
[No Abstract] [Full Text] [Related]
16. Relative transmissibility of an R5 clade C simian-human immunodeficiency virus across different mucosae in macaques parallels the relative risks of sexual HIV-1 transmission in humans via different routes.
Chenine AL; Siddappa NB; Kramer VG; Sciaranghella G; Rasmussen RA; Lee SJ; Santosuosso M; Poznansky MC; Velu V; Amara RR; Souder C; Anderson DC; Villinger F; Else JG; Novembre FJ; Strobert E; O'Neil SP; Secor WE; Ruprecht RM
J Infect Dis; 2010 Apr; 201(8):1155-63. PubMed ID: 20214475
[TBL] [Abstract][Full Text] [Related]
17. Barriers to mucosal transmission of immunodeficiency viruses.
Keele BF; Estes JD
Blood; 2011 Jul; 118(4):839-46. PubMed ID: 21555745
[TBL] [Abstract][Full Text] [Related]
18. Use of nonhuman primate models to develop mucosal AIDS vaccines.
Genescà M; Miller CJ
Curr HIV/AIDS Rep; 2010 Feb; 7(1):19-27. PubMed ID: 20425054
[TBL] [Abstract][Full Text] [Related]
19. Repetitive exposures with simian/human immunodeficiency viruses: strategy to study HIV pre-clinical interventions in non-human primates.
Kim CN; Adams DR; Bashirian S; Butera S; Folks TM; Otten RA
J Med Primatol; 2006 Aug; 35(4-5):210-6. PubMed ID: 16872284
[TBL] [Abstract][Full Text] [Related]
20. Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection.
Baba TW; Liska V; Hofmann-Lehmann R; Vlasak J; Xu W; Ayehunie S; Cavacini LA; Posner MR; Katinger H; Stiegler G; Bernacky BJ; Rizvi TA; Schmidt R; Hill LR; Keeling ME; Lu Y; Wright JE; Chou TC; Ruprecht RM
Nat Med; 2000 Feb; 6(2):200-6. PubMed ID: 10655110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
